Several of the original co-founders of Bioprocess Control buy-out the current investors and restructure the board. Our CEO, Dr. Jing Liu becomes a majority owner of Bioprocess Control and will continue to lead the company as it enters a new exciting development phase.
Bioprocess Control has gone through an exciting journey over the past 10 years, from a university spin-off to a successful company with product sales in over 60 countries. Today, Bioprocess Control is well-recognised as a market leader within the area of low gas flow analytical instruments that allow for more efficient and higher quality research and analysis, leading to significant reductions in time, labour and required skills.
Taking an innovative idea and turning it into a unique product with a clear value proposition is hard work and most always requires passion and a strong entrepreneurial spirt. To achieve this, it is essential to have complete alignment between the management team and owners. In the recent share transaction, Dr. Jing Liu who is a co-founder and lead inventor, is jointed by two other co-founders and LU Innovation, with Dr. Jing Liu becoming the majority shareholder of Bioprocess Control. Following this transaction, a new board was has elected consisting Prof. Gustaf Olsson, Mr. Kristofer Cook and Dr. Jing Liu. All board members are co-founders and owners of Bioprocess Control and hold a common long-term vision for developing the company in the years to come. Bioprocess Control stands well prepared to capitalise on current and future products and meet new opportunities as well as any challenges along the way.
To learn more about new board of directors at Bioprocess Control, please visit Management section.